Impact of inducible ischemia by stress SPECT in cardiac risk assessment in diabetic patients: Rationale and design of a prospective, multicenter trial

Journal of Nuclear Cardiology

Volumn 15, Issue 1, 2008, Pages 100-104

  Petretta, Mario ^a   Acampa, Wanda ^a,b,c   Evangelista, Laura ^a   Daniele, Stefania ^a,b,c   Ferro, Adele ^a,b   Cuocolo, Alberto ^a,b,c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c IRCCS SDN   (Italy)

Author keywords

diabetes mellitus; Inducible ischemia; single photon emission computed tomography imaging

Indexed keywords

DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE DURATION; EXERCISE TEST; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART SCINTISCANNING; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REST; RISK ASSESSMENT; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT ELEVATION;

COMORBIDITY; DIABETES MELLITUS; EXERCISE TEST; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREVALENCE; PROSPECTIVE STUDIES; RESEARCH; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 38649115019     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2007.09.026     Document Type: Article

References (29)

1. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., and Laakso M. Mortality from coronary artery disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339 (1998) 229-234
2. May O., Arildsen H., Damsgaard E.M., and Mickley H. Prevalence and prediction of silent ischemia in diabetes mellitus: a population-based study. Cardiovasc Res 34 (1997) 241-247
3. Hachamovitch R., Hayes S.W., Friedman J.D., Cohen I., and Berman D.S. Comparison of short-term survival benefit associated with revascularization compared with medically therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 107 (2003) 2900-2907
4. Raggi P., Bellasi A., and Ratti C. Ischemia imaging and plaque imaging in diabetes: complementary tools to improve cardiovascular risk management. Diabetes Care 28 (2005) 2787-2794
5. Anand D.V., Lim E., Hopkins D., Corder R., Shaw L.J., Sharp P., et al. Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J 27 (2006) 713-721
6. Kang X., Berman D.S., Lewin H., Miranda R., Erel J., Friedman J.D., et al. Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with without diabetes mellitus. Am Heart J 137 (1999) 949-957
7. Giri S., Shaw L.J., Murthy D.R., Travin M.I., Miller D.D., Hachamovitch R., et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 105 (2002) 32-40
8. Shaw L.J., Berman D.S., Hendel R.C., Alazraki N., Krawczynska E., Borges-Neto S., et al. Cardiovascular disease risk stratification with stress single-photon emission computed tomography technetium-99m tetrofosmin imaging in patients with the metabolic syndrome and diabetes mellitus. Am J Cardiol 97 (2006) 1538-1544
9. Miller T.D., Rajagopalan N., Hodge D.O., Frye R.L., and Gibbons R.J. Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes. Am Heart J 147 (2004) 890-896
10. Rajagopalan N., Miller T.D., Hodge D.O., Frye R.L., and Gibbons R.J. Identify high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. J Am Coll Cardiol 45 (2005) 43-49
11. Zellweger M.J., Hachamovitch R., Kang X., Hayes S.W., Friedman J.D., Germano G., et al. Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. Eur Heart J 25 (2004) 543-550
12. De Lorenzo A., Lima R.S., Siqueira-Filho A.G., and Pantoja M.R. Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol 90 (2002) 827-832
13. Wackers F.J., Young L.H., Inzucchi S.E., Chyun D.A., Davey J.A., Barrett E.J., et al., Detection of ischemia in asymptomatic diabetics investigators. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 27 (2004) 1954-1961
14. Bax J.J., Bonow R.O., Tschope D., Inzucchi S.E., Barrett E., and Global Dialogue Group for the Evaluation of Cardiovascular Risk in Patients With Diabetes. The potential of myocardial perfusion scintigraphy for risk stratification of asymptomatic patients with type 2 diabetes. J Am Coll Cardiol 48 (2006) 754-760
15. American Diabetes Association. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida. Diabetes Care 21 (1998) 1551-1559
16. Hachamovitch R., Berman D.S., Kiat H., Cohen I., Cabico J.A., Friedman J., et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 93 (1996) 905-914
17. Hachamovitch R., Berman D.S., Shaw L.J., Kiat H., Cohen I., Cabico J.A., et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 97 (1998) 535-543
18. Iskandrian A.S., Chae S.C., Heo J., Stanberry C.D., Wasserleben V., and Cave V. Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease. J Am Coll Cardiol 22 (1993) 665-670
19. Shaw L.J., Hachamovitch R., Heller G.V., Marwick T.H., Travin M.I., Iskandrian A.E., et al., The Economics of Noninvasive Diagnosis (END) Study Group. Noninvasive strategies for the estimation of cardiac risk in stable chest pain patients. Am J Cardiol 86 (2000) 1-7
20. Hachamovitch R., Berman D.S., Kiat H., Cohen I., Friedman J.D., and Shaw L.J. Value of stress myocardial perfusion single photon emission computed tomography in patients with normal resting electrocardiograms: an evaluation of incremental prognostic value and cost-effectiveness. Circulation 105 (2002) 823-829
21. Berman D.S., Hachamovitch R., Kiat H., Cohen I., Cabico J.A., Wang F.P., et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 26 (1995) 639-647
22. Di Carli M.F., and Hachamovitch R. Should we screen for occult coronary artery disease among asymptomatic patients with diabetes?. J Am Coll Cardiol 45 (2005) 50-53
23. Diamond G.A., Staniloff H.M., Forrester J.S., Pollok B.H., and Swan H.J.C. Computer-assisted diagnosis in the noninvasive evaluation of patients with suspected coronary artery disease. J Am Coll Cardiol 1 (1983) 444-455
24. Acampa W., Evangelista L., Petretta M., Liuzzi R., and Cuocolo A. Usefulness of stress cardiac single-photon emission computed tomographic imaging late after percutaneous coronary intervention for assessing cardiac events and time to such events. Am J Cardiol 100 (2007) 436-441
25. Hansen C.L., Goldstein R.A., Berman D.S., Churchwell K.B., Cooke C.D., Corbett J.R., et al., Quality Assurance Committee of the American Society of Nuclear Cardiology. Myocardial perfusion and function single photon emission computed tomography. J Nucl Cardiol 13 (2006) e97-e120
26. Cerqueira M.D., Weissman N.J., Dilsizian V., Jacobs A.K., Kaul S., Laskey W.K., et al., American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105 (2002) 539-542
27. Germano G., Kavanagh P.B., Waechter P., Areeda J., Van Kriekinge S., Sharir T., et al. A new algorithm for the quantitation of myocardial perfusion SPECT. I: technical principles and reproducibility. J Nucl Med 41 (2000) 712-719
28. Sharir T., Germano G., Kang X., Lewin H.C., Miranda R., Cohen I., et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med 42 (2001) 831-837
29. Hachamovitch R., Hayes S.W., Friedman J.D., Cohen I., and Berman D.S. Stress myocardial perfusion single-photon emission computed tomography is clinically effective and cost effective in risk stratification of patients with a high likelihood of coronary artery disease (CAD) but no known CAD. J Am Coll Cardiol 43 (2004) 200-208